BioCentury
ARTICLE | Company News

Amgen, Amylin, Gryphon Sciences Inc. deal

March 6, 2006 8:00 AM UTC

AMLN disclosed on its quarterly conference call last month that it acquired rights to AMGN's leptin program. AMGN originally acquired the program from Rockefeller University (New York, N.Y.) in 1995 for $20 million. ...